Miles P. Davenport
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 199 publications
Reconciliation of titer differences between SARS-CoV-2 neutralizing antibody assays.
Journal: Journal of virology
Published: August 27, 2026
Accelerating the research response to the Bundibugyo virus emergency.
Journal: Nature immunology
Published: August 14, 2026
The rebound-initiating viral reservoir (RIVR) in SIV/SHIV infection is dominated by plasma virus sequences present at the time of ART initiation.
Journal: Journal of virology
Published: July 28, 2026
External validity for in vitro toxicity studies: an important but challenging concept.
Journal: Regulatory toxicology and pharmacology : RTP
Published: June 30, 2026
Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: April 16, 2026
Dissecting the steps in early simian immunodeficiency virus dissemination following mucosal and intravenous infection of rhesus macaques.
Journal: Journal of virology
Published: February 18, 2026
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity.
Journal: Nature communications
Published: January 19, 2026
Searching for immune correlates in Lassa vaccine development - workshop report.
Journal: NPJ vaccines
Published: December 20, 2025
Therapeutic CD8+ T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 14, 2025
Neutralising antibodies and protection from progression to severe COVID-19: A meta-analysis.
Journal: PLoS medicine
Published: July 29, 2025
Last Updated: 09/26/2026